filmov
tv
Improving outcomes for patients with metastatic NSCLC with immunotherapy
![preview_player](https://i.ytimg.com/vi/n876KAMfgeQ/maxresdefault.jpg)
Показать описание
Mirjana Rajer, MD, PhD, Institute of Oncology Ljubljana, Ljubljana, Slovenia, talks on the introduction of immunotherapy into the treatment landscape for patients with metastatic non-small cell lung cancer (NSCLC), and how this has improved patient outcomes. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.